Prostate Cancer Clinical Trials in San Diego

Showing 61-80 of 216 trials

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

NCT01995058

This study was conducted in subjects in chemotherapy-naïve subjects with bone-metastatic castration-resistant prostate cancer (CRPC).

Prostate CancerCastration Resistant Prostate CancerProstatic Neoplasms

Exelixis54 participantsStarted Feb 2014

Scottsdale, Arizona, United States • Sedona, Arizona, United States • Tucson, Arizona, United States +17 more locations

COMPLETEDPhase 3< 1 mile

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

NCT03009981

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.

Prostate Cancer

Alliance Foundation Trials, LLC.504 participantsStarted Mar 2017

Phoenix, Arizona, United States • Chula Vista, California, United States • Duarte, California, United States +66 more locations

Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Prostate Cancer Trials in Other Cities

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Folate Study in Men With Advanced Prostate Cancer

A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Other Conditions in San Diego